Genetic Signatures Ltd (GSS) — Cash Flow-to-Debt Ratio
Genetic Signatures Ltd (GSS) has a Cash Flow-to-Debt Ratio of -0.07x as of December 2025, meaning its operating cash flow of AU$-349.00K could theoretically repay 0% of its total liabilities (AU$4.95 Million) in one year. See GSS free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Genetic Signatures Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Genetic Signatures Ltd across 13 annual periods. Also explore how fast is Genetic Signatures Ltd growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Genetic Signatures Ltd (2013–2025)
Year-by-year debt coverage analysis for Genetic Signatures Ltd. For market capitalisation and broader financial context, see market value of Genetic Signatures Ltd.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.71x | AU$-12.29 Million | AU$4.54 Million | ▼ -65.5% |
| 2024 | -1.64x | AU$-10.12 Million | AU$6.18 Million | ▲ +19.0% |
| 2023 | -2.02x | AU$-12.45 Million | AU$6.16 Million | ▼ -199.9% |
| 2022 | 2.02x | AU$9.81 Million | AU$4.85 Million | ▲ +126.8% |
| 2021 | 0.89x | AU$4.20 Million | AU$4.71 Million | ▲ +135.5% |
| 2020 | -2.51x | AU$-9.49 Million | AU$3.79 Million | ▼ -72.5% |
| 2019 | -1.45x | AU$-2.27 Million | AU$1.56 Million | ▲ +52.4% |
| 2018 | -3.05x | AU$-3.69 Million | AU$1.21 Million | ▼ -41.3% |
| 2017 | -2.16x | AU$-2.57 Million | AU$1.19 Million | ▼ -7.9% |
| 2016 | -2.00x | AU$-2.57 Million | AU$1.28 Million | ▲ +46.7% |
| 2015 | -3.76x | AU$-2.80 Million | AU$743.14K | ▼ -2.9% |
| 2014 | -3.66x | AU$-1.35 Million | AU$370.48K | ▼ -1203.5% |
| 2013 | -0.28x | AU$-1.19 Million | AU$4.23 Million | — |